Celgene (CELG) Q1 2012 Earnings Call April 26, 2012 9:00 am ET Executives Patrick E. Flanigan III - Robert J. Hugin - Chairman, Chief Executive Officer, President, Secretary and Chairman of Executive Committee Jacqualyn A. Fouse - Chief Financial Officer and Senior Vice President Mark J. Alles - Chief Commercial Officer and Executive Vice President Analysts Geoffrey C. Meacham - JP Morgan Chase & Co, Research Division Marshall Urist - Morgan Stanley, Research Division Mark J. Schoenebaum - ISI Group Inc., Research Division Navdeep Singh - Deutsche Bank AG, Research Division Eric Schmidt - Cowen and Company, LLC, Research Division Gene Mack - Mizuho Securities USA Inc., Research Division Sapna Srivastava - Goldman Sachs Group Inc., Research Division Brian Abrahams - Wells Fargo Securities, LLC, Research Division Aleksandr Rabodzey Rachel L. McMinn - BofA Merrill Lynch, Research Division Joel D. Sendek - Stifel, Nicolaus & Co., Inc., Research Division Yaron Werber - Citigroup Inc, Research Division Christopher J. Raymond - Robert W. Baird & Co. Incorporated, Research Division Nicholas Abbott - BMO Capital Markets U.S. Ravi Mehrotra - Crédit Suisse AG, Research Division Michael G. King - Rodman & Renshaw, LLC, Research Division Matthew Roden - UBS Investment Bank, Research Division PresentationOperator
Good day, ladies and gentlemen, and welcome to the Celgene Corporation First Quarter 2012 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the call over to your host, Patrick Flanigan, Vice President of Investor Relations. Please go ahead. Patrick E. Flanigan III Thanks, Stephanie, and welcome, everyone, to Celgene Corporation's First Quarter Earnings Conference Call. The press release reporting our first quarter results, in addition to the presentation for today's webcast, can be accessed by going to the Investor Relations section of the corporate website at www.celgene.com.